N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine

C160H191FN32O10S2 — CID 160624449

About N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine

N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine (PubChem CID 160624449) has the molecular formula C160H191FN32O10S2 and a molecular weight of 2805.63 g/mol. Its IUPAC name is N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine.

Molecular Properties

• Compound Name: N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine
• PubChem CID: 160624449
• Molecular Formula: C160H191FN32O10S2
• Molecular Weight: 2805.63 g/mol
• Exact Mass: 2803.48
• IUPAC Name: N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine
• SMILES: CNCc1ccccc1-c1ccc([C@@H](C)Nc2nnc(C)c3ccc(O[C@H]4CCOC4)cc23)s1.Cc1c([C@@H](C)Nc2nnc(C)c3cnc(N4CCOCC4)cc23)cccc1S(C)(=O)=O.Cc1cc(F)cc([C@@H](C)Nc2nnc(C)c3cnc(N4CCOCC4)cc23)c1.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(OC4CCNCC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(O[C@H]4CCNC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(N4CCOCC4)cc23)c1.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(N4CCOCC4)cc23)c1C
• InChI: InChI=1S/C27H30N4O2S.C24H30N4O.C23H28N4O.C22H27N5O3S.C22H27N5O.C21H24FN5O.C21H25N5O/c1-17-22-9-8-20(33-21-12-13-32-16-21)14-24(22)27(31-30-17)29-18(2)25-10-11-26(34-25)23-7-5-4-6-19(23)15-28-3;1-15-6-5-7-21(16(15)2)17(3)26-24-23-14-20(29-19-10-12-25-13-11-19)8-9-22(23)18(4)27-28-24;1-14-6-5-7-20(15(14)2)16(3)25-23-22-12-18(28-19-10-11-24-13-19)8-9-21(22)17(4)26-27-23;1-14-17(6-5-7-20(14)31(4,28)29)15(2)24-22-18-12-21(27-8-10-30-11-9-27)23-13-19(18)16(3)25-26-22;1-14-6-5-7-18(15(14)2)16(3)24-22-19-12-21(27-8-10-28-11-9-27)23-13-20(19)17(4)25-26-22;1-13-8-16(10-17(22)9-13)14(2)24-21-18-11-20(27-4-6-28-7-5-27)23-12-19(18)15(3)25-26-21;1-14-5-4-6-17(11-14)15(2)23-21-18-12-20(26-7-9-27-10-8-26)22-13-19(18)16(3)24-25-21/h4-11,14,18,21,28H,12-13,15-16H2,1-3H3,(H,29,31);5-9,14,17,19,25H,10-13H2,1-4H3,(H,26,28);5-9,12,16,19,24H,10-11,13H2,1-4H3,(H,25,27);5-7,12-13,15H,8-11H2,1-4H3,(H,24,26);5-7,12-13,16H,8-11H2,1-4H3,(H,24,26);8-12,14H,4-7H2,1-3H3,(H,24,26);4-6,11-13,15H,7-10H2,1-3H3,(H,23,25)/t18-,21+;17-;16-,19+;15-;16-;14-;15-/m1111111/s1
• InChIKey: RHCPAQFGUNOXQX-XGWGFQFBSA-N
• XLogP: 29.51
• TPSA: 473.26 Ų
• H-Bond Donors: 10
• H-Bond Acceptors: 43
• Rotatable Bonds: 35
• Heavy Atoms: 205
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2805.63
LogP ≤ 5	29.51
H-Bond Donors ≤ 5	10
H-Bond Acceptors ≤ 10	43

Frequently Asked Questions

What is the IUPAC name of N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine?

The IUPAC name of N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine (CID 160624449) is N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine.

What is the SMILES notation for N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine?

The canonical SMILES for N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine is CNCc1ccccc1-c1ccc([C@@H](C)Nc2nnc(C)c3ccc(O[C@H]4CCOC4)cc23)s1.Cc1c([C@@H](C)Nc2nnc(C)c3cnc(N4CCOCC4)cc23)cccc1S(C)(=O)=O.Cc1cc(F)cc([C@@H](C)Nc2nnc(C)c3cnc(N4CCOCC4)cc23)c1.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(OC4CCNCC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3ccc(O[C@H]4CCNC4)cc23)c1C.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(N4CCOCC4)cc23)c1.Cc1cccc([C@@H](C)Nc2nnc(C)c3cnc(N4CCOCC4)cc23)c1C.

What is the InChIKey of N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine?

The InChIKey is RHCPAQFGUNOXQX-XGWGFQFBSA-N. The full InChI is InChI=1S/C27H30N4O2S.C24H30N4O.C23H28N4O.C22H27N5O3S.C22H27N5O.C21H24FN5O.C21H25N5O/c1-17-22-9-8-20(33-21-12-13-32-16-21)14-24(22)27(31-30-17)29-18(2)25-10-11-26(34-25)23-7-5-4-6-19(23)15-28-3;1-15-6-5-7-21(16(15)2)17(3)26-24-23-14-20(29-19-10-12-25-13-11-19)8-9-22(23)18(4)27-28-24;1-14-6-5-7-20(15(14)2)16(3)25-23-22-12-18(28-19-10-11-24-13-19)8-9-21(22)17(4)26-27-23;1-14-17(6-5-7-20(14)31(4,28)29)15(2)24-22-18-12-21(27-8-10-30-11-9-27)23-13-19(18)16(3)25-26-22;1-14-6-5-7-18(15(14)2)16(3)24-22-19-12-21(27-8-10-28-11-9-27)23-13-20(19)17(4)25-26-22;1-13-8-16(10-17(22)9-13)14(2)24-21-18-11-20(27-4-6-28-7-5-27)23-12-19(18)15(3)25-26-21;1-14-5-4-6-17(11-14)15(2)23-21-18-12-20(26-7-9-27-10-8-26)22-13-19(18)16(3)24-25-21/h4-11,14,18,21,28H,12-13,15-16H2,1-3H3,(H,29,31);5-9,14,17,19,25H,10-13H2,1-4H3,(H,26,28);5-9,12,16,19,24H,10-11,13H2,1-4H3,(H,25,27);5-7,12-13,15H,8-11H2,1-4H3,(H,24,26);5-7,12-13,16H,8-11H2,1-4H3,(H,24,26);8-12,14H,4-7H2,1-3H3,(H,24,26);4-6,11-13,15H,7-10H2,1-3H3,(H,23,25)/t18-,21+;17-;16-,19+;15-;16-;14-;15-/m1111111/s1.

What are the key properties of N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine?

N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine has a molecular weight of 2805.63 g/mol, XLogP of 29.51, 35 rotatable bonds, 10 hydrogen bond donors, and 43 hydrogen bond acceptors.

Where does this data come from?

All data for N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-piperidin-4-yloxyphthalazin-1-amine;N-[(1R)-1-(2,3-dimethylphenyl)ethyl]-4-methyl-7-[(3S)-pyrrolidin-3-yl]oxyphthalazin-1-amine;N-[(1R)-1-(3-fluoro-5-methylphenyl)ethyl]-4-methyl-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-[5-[2-(methylaminomethyl)phenyl]thiophen-2-yl]ethyl]-7-[(3S)-oxolan-3-yl]oxyphthalazin-1-amine;4-methyl-N-[(1R)-1-(2-methyl-3-methylsulfonylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine;4-methyl-N-[(1R)-1-(3-methylphenyl)ethyl]-7-morpholin-4-ylpyrido[3,4-d]pyridazin-1-amine is sourced from PubChem (CID 160624449), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).